Search
CELL BANK Website

Back Back
Cell No. : Cell Name
RCB1731 : TM-31  update : 2024/08/05
CommentHuman cell line derived from astrocytoma developed in a patient with NF-1 (neurofibromatosis type 1)
Comment from the depositor
Terms and conditionsThere is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC.
Remarks
Order Form Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
Basic information Depositor Kurimoto, Masanori
Originator Kurimoto, Masanori
Year of deposit 2001
Animal _human < Mammals
Genus Homo
Species sapiens
Race Japanese
Gender Female
Age at sampling 42 years
Tissue brain
Disease name malignant astrocytoma
Classification cancer
Lifespan infinite
Morphology fibroblast-like
Cellosaurus(Expasy) CVCL_6735
deposit info
lot info
Medium Medium List
Culture type Adherent cells
Culture medium MEM + 10% FBS
Antibiotics Free
Passage method 0.25% Trypsin
Culture information Passage ratio 1 : 8 split
SC frequency Subculture : once/week, Medium Renewal : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
Isozyme LD, NP
Chromosome mode 72-153(50) : /74(8),75(7),76(7),77(8),78(1),142(1)/
STR(human) OK
Reference information Reference 1
User's Publication 2


To topTop
Reference
2694  Kurimoto M, Hirashima Y, Ogiichi T, Hamada H, Kamiyama H, Endo S  Establishment and characterization of a novel malignant astrocytoma cell line derived from a tumor removed in a patient with neurofibromatosis type 1.  J Neurosurg  2001  94:301-8  PubMed ID: 11213969   DOI: 10.3171/jns.2001.94.2.0301

To topTop
User's Publication
19506  Dougherty J, Harvey K, Liou A, Labella K, Moran D, Brosius S, De Raedt T.  Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas  PLoS One  2023  18(2):e0277305  PubMed ID: 36730269   DOI: 10.1371/journal.pone.0277305
4672  Ohka F, Shinjo K, Deguchi S, Matsui Y, Okuno Y, Katsushima K, Suzuki M, Kato A, Ogiso N, Yamamichi A, Aoki K, Suzuki H, Sato S, Arul Rayan N, Prabhakar S, Göke J, Shimamura T, Maruyama R, Takahashi S, Suzumura A, Kimura H, Wakabayashi T, Zong H, Natsume A, Kondo Y.  Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-wild-type Diffuse Astrocytic Gliomas.  Cancer Res  2019  79(19):4814-4827  PubMed ID: 31431463   DOI: 10.1158/0008-5472.CAN-19-1272



Back Back Return Top Page